Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |